Related Experiment Videos
[Cardiovascular disturbances in acromegaly]
Daniela Fedrizzi1, Mauro Antonio Czepielewski
1Unidade de Neuroendocrinologia, Serviço de Endocrinologia, Hospital de Clínicas de Porto Alegre. danifedrizzi@hotmail.com
Insights
Acromegaly, caused by excess growth hormone (GH) and insulin-like growth factor 1 (IGF-1), leads to serious cardiovascular issues like cardiomyopathy and arrhythmias. Effective treatment can improve these conditions and patient survival.
Area of Science:
- Endocrinology
- Cardiology
- Internal Medicine
Background:
- Acromegaly, a disorder of excess growth hormone (GH) and insulin-like growth factor 1 (IGF-1), significantly impacts cardiovascular health.
- Cardiovascular complications are the primary cause of increased mortality in acromegaly patients.
Purpose of the Study:
- To review the clinical and prognostic aspects of cardiovascular disorders in acromegaly.
- To evaluate the effects of acromegaly treatment on cardiovascular manifestations and patient survival.
Main Methods:
- Literature review of clinical studies and case reports on acromegaly and cardiovascular disease.
- Analysis of the pathophysiology, clinical presentation, and treatment outcomes of cardiovascular complications.
Main Results:
- Acromegalic cardiomyopathy progresses from a hyperdynamic state to hypertrophy, diastolic dysfunction, and potentially systolic dysfunction and heart failure.
- Other significant cardiovascular issues include arrhythmias, heart valve disease (mitral/aortic), ischemic heart disease, hypertension, and metabolic disorders.
Conclusions:
- Cardiovascular complications are a major determinant of prognosis in acromegaly.
- Treatment of acromegaly can positively impact cardiovascular health and improve patient survival, highlighting the importance of timely diagnosis and management.
Abstract:
Acromegaly causes a number of disorders in the cardiovascular system, resulting from chronic exposure to high levels of GH and IGF-1. Such disorders are the main responsible for increased mortality rates among acromegalic patients. Among several forms of cardiovascular impairment is acromegalic cardiomyopathy, an entity that is initially characterized by a hyperdynamic state, followed by concentric left ventricular hypertrophy and diastolic dysfunction due to relaxation deficit, culminating in systolic dysfunction and sometimes heart failure. In addition, arrhythmias and heart valve diseases are also relevant, especially mitral and aortic, ischemic heart disease, hypertension, and glucose and lipid metabolism disorders. This review approaches the main clinical and prognostic aspects of these entities, the effects of acromegaly treatment on them, and the respective consequences on patient survival.
Related Concept Videos
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure III: Clinical Manifestations
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cardiovascular System Abnormal Findings II: Auscultation
Abnormal Heart Sounds
Gallops: